EichorEICHOR
Study identifier: NCT05756322 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Recruiting

The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias

Condition: Relapsed or Resistant Acute Leukaemias  ·  Sponsor: Lin BioScience, Inc

PhasePhase 1/Phase 2
Planned participants90
Who can joinAll sexes, 18 Years to 120 Years
Healthy volunteersNo

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

The most common types of acute leukaemia are acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML). AML is a heterogenous clonal disorder of haemopoietic progenitor cells and the most common and severe malignant leukemia in adults and is responsible for the highest mortality from leukemia. ALL is a neoplasm characterized by the growth of malignant lymphoblasts of the B or T lineage, leading to an inhibition of proliferation of the normal blood cell lineages. The primary objectives of this study are investigating the safety, tolerability, and the MTD of LBS-007. The secondary objectives are to assess the efficacy and to determine the pharmacokinetics (PK) of LBS-007. The exploratory objective is to study and correlate the changes in surrogate biomarkers in response to treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Lin BioScience Clinical Operations  ·  +886975781753  ·  clinicaltrial@linbioscience.com

Always discuss trial participation with your own doctor first.

Locations (17)

Moffitt Cancer CenterTampa, Florida, United StatesRecruiting
Robert H. Lurie Comprehensive Cancer Center of Northwestern UniversityChicago, Illinois, United StatesNot Yet Recruiting
The University of Kansas HospitalFairway, Kansas, United StatesRecruiting
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsBaltimore, Maryland, United StatesRecruiting
UNC Hospitals, The University of North Carolina at Chapel HillChapel Hill, North Carolina, United StatesRecruiting
Wollongong Private HospitalWollongong, New South Wales, AustraliaCompleted
Pindara Private HospitalBenowa, Queensland, AustraliaCompleted
The Royal Adelaide HospitalAdelaide, South Australia, AustraliaRecruiting
The Alfred HospitalMelbourne, Victoria, AustraliaActive Not Recruiting
Hollywood Private HospitalNedlands, Washington, AustraliaWithdrawn
Q Medical ConsellingPerth, Washington, AustraliaWithdrawn
The First Affiliated Hospital of Xinxiang Medical UniversityXinxiang, Henan, ChinaRecruiting

+ 5 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →